Skip to main content
Questions about giving or our research? Call us — (800) 321-2873 Donor help Search

by
Blog
February 15, 2022

[vc_row][vc_column][vc_single_image image="47541" img_size="Full" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Cases of skin cancer are skyrocketing. In the past three decades, more people have been diagnosed with some form of skin cancer than all other cancers combined. Because of this, researchers worldwide have been fascinated with figuring out how to better...

, , ,

by
Blog
November 26, 2021

[vc_row][vc_column][vc_single_image image="46166" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]Glioblastoma multiforme (GBM) is the most aggressive malignant brain tumor in adults, with a median survival of only about ten months. Unlike low-grade gliomas (grades I and II), which grow slowly, high-grade gliomas (grades III and IV) grow much faster...

, , ,

by
Blog
August 19, 2021

[vc_row][vc_column][vc_single_image image="44142" img_size="full" alignment="center" css=""][vc_empty_space height="22px"][vc_column_text css=""]Seizures are a severe complication of a brain tumor. An estimated 35-70 % of brain tumor patients may have a seizure(s) in the course of the disease, and 20-40 percent of the patients may have seizures as their first...

, , ,

by
Blog
February 10, 2021

[vc_row][vc_column][vc_single_image image="40602" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]National Foundation for Cancer Research-funded researcher Dr. Daniel A Haber recently unearthed an exciting discovery that may add years to the lives of late-stage breast cancer patients. Dr. Haber is fascinated by understanding drug resistance on a deeper level by studying...

, ,

by
Blog
May 21, 2020

[vc_row][vc_column][vc_single_image image="33537" img_size="full" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""] Much like a scorpion uses toxin components to target and kill its prey, the research team at City of Hope are using it to direct T cells to target the cancerous cells. Each year, as the ground begins to thaw, people...

by
Blog, Coronavirus
May 8, 2020

[vc_row][vc_column][vc_column_text] Note: This is part two of Dr. Michael Wang's series that specifically addresses Brain Cancer Treatment during the Coronavirus Pandemic. You can read part one here. In addition to surgery, radiation therapy and chemotherapy are the other two major medical procedures to treat brain cancers. Patients...

, ,

by
Blog, Rare Cancer
February 6, 2020

[vc_row][vc_column][vc_single_image image="31523" img_size="full" add_caption="yes" alignment="center" css=""][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=""]In a paper published in the science journal Nature, Yale University scientists showed that application of Vascular Endothelial Growth Factor C (VEGF-C) increased the human body’s natural immune response to glioblastoma, a form of brain cancer. VEGF-C is a member...

, , ,